kolate.AI
clinical trial events prediction engine
Gen AI for clinical trials
partner with us
The Challenge
During clinical trials, pharma's lack effective advance warning of upcoming trial events and resultant changes in trajectory - as such, they are forced to continue non-working trials, and not take proactive actions on trials that are working
AI enabled events prediction engine
Gen AI based trial events prediction engine for sponsor stakeholders (initial focus on AE’s, SAE’s, hospitalizations) that delivers real-time insights to enable in-trial adjustments and improved execution
Patient Stratification for Precision Medicine
Chatbots for real-time trial insights
How can Gen AI insights improve your drug trials?
About us
The founders are Vinodh Balaraman and Sridhar Byrapppa, both tech-savvy repeat entrepreneurs. Between us, we have 40+ years of pharma industry experience and expertise in business growth and execution. We have experienced the problems with drug development firsthand. Vinodh has worked on large life sciences consulting assignments and led multifold growth as a Senior Partner at ZS and SVP at Atos. He is an IIT Chennai graduate and has an MBA from Chicago Booth. Sridhar has operational experience at large pharma companies (Merck, Wyeth, Schering Plough, BMS and Stryker). He has a Ph.D. in Microbiology and has firsthand experience with the travails of drug development and executing large global clinical trials. It is our collective effort to bring cutting-edge technologies to drug development - speed up drug trials, reduce development failure rates, and get a greater number of drugs to the market.
Speed up your drug trials with real-time trial insights
Reduce time and cost of drug development
Develop a greater number of drugs
partner with us
vinodh@kolate.ai
sridhar@kolate.ai
Kolate AI Inc
Belle Mead, NJ